Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas

被引：1
|
作者：
Kothari, Atul [1 ,2 ]
Borella, Elizabeth Woodland [1 ]
Smith, Michelle R. [1 ]
机构：
[1] Arkansas Dept Hlth, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Med & Biomed Informat, Little Rock, AR 72205 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 01期
关键词：
COVID; 19; monoclonal antibodies;
D O I：
10.1093/ofid/ofab602
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
COVID-19 monoclonal antibodies revolutionized the treatment for eligible patients who have tested positive for SARS CoV-2 infection in an ambulatory setting. In this short report, we describe our experience assisting in the distribution of monoclonal antibodies in Arkansas during the summer surge of the delta variant.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Impact of Immunosuppressive Therapy, Vaccination, and Monoclonal Antibody Use With Outcomes in Liver and Kidney Transplant Recipients With COVID-19: A Retrospective Study
    Francis, Ashley
    Chaudhary, Ammad Javaid
    Sohail, Abdullah
    Tarar, Zahid I.
    Jaan, Ali
    Cavataio, Joseph P.
    Farooqui, Sara
    Varma, Adarsh
    Jafri, Syed-Mohammed
    JGH OPEN, 2024, 8 (12):
  • [22] Implementation of an Emergency Department-Embedded Infusion Center for the Administration of Monoclonal Antibody Therapy in Patients With Early COVID-19 Infection
    Graham, Julie
    Ballejos, Christina
    Jenkins, Danisha
    Kelley, Christina
    JOURNAL OF INFUSION NURSING, 2022, 45 (01) : 41 - 48
  • [23] The (apparent) antibody paradox in COVID-19
    Ameratunga, Rohan
    Woon, See-Tarn
    Lea, Edward
    Steele, Richard
    Lehnert, Klaus
    Leung, Euphemia
    Brooks, Anna E. S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (04) : 335 - 345
  • [24] Understanding Antibody Testing for COVID-19
    Jacofsky, David
    Jacofsky, Emilia M.
    Jacofsky, Marc
    JOURNAL OF ARTHROPLASTY, 2020, 35 (07) : S74 - S81
  • [25] Ivermectin & COVID-19: Let's keep a One Health perspective
    Domingo-Echaburu, Saioa
    Orive, Gorka
    Lertxundi, Unax
    SUSTAINABLE CHEMISTRY AND PHARMACY, 2021, 21
  • [26] COVID-19 and alcohol in Australia: Industry changes and public health impacts
    Colbert, Stephanie
    Wilkinson, Claire
    Thornton, Louise
    Richmond, Robyn
    DRUG AND ALCOHOL REVIEW, 2020, 39 (05) : 435 - 440
  • [27] Evaluating the industrial hygiene, toxicology, and public health aspects of COVID-19
    Hollins, Dana
    Kiorpes, Anthony L.
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2020, 36 (09) : 605 - 606
  • [28] Lessons learned and real-world insights from implementing neutralizing monoclonal antibody programs for treatment of COVID-19
    Ambrose, Nalini
    Amin, Alpesh N.
    Anderson, Brian
    Aten, Adam
    Canter, Brian
    Chow, Daniel
    Ambrosio, Matthew D. '
    Danan, Risa
    Drews, Ashley L.
    Gaspar, Fraser W.
    Hendricks-Sturrup, Rachele
    Horo, John O. '
    Razonable, Raymund R.
    Roberts, Seth
    Shepard, Colin
    Vahidy, Farhaan
    Webb, Brandon
    Yttri, Jennifer
    DATA & POLICY, 2024, 6
  • [29] A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities
    Tulledge-Scheitel, Sidna
    Bell, Sarah J.
    Larsen, Jennifer J.
    Bierle, Dennis M.
    Takahashi, Paul
    Moehnke, Darcie E.
    Destro Borgen, Molly J.
    Springer, Donna J.
    Reinschmidt, Karen J.
    Baumbach, Lori J.
    Matoush, Jennifer A.
    Heyliger, Alexander
    Hanson, Sara N.
    Razonable, Raymund R.
    Ganesh, Ravindra
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (04) : 868 - 873
  • [30] The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic
    Dass, Sylvia Annabel
    Balakrishnan, Venugopal
    Arifin, Norsyahida
    Lim, Crystale Siew Ying
    Nordin, Fazlina
    Tye, Gee Jun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345